Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing.
- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing.
- This investment spans a portfolio of technology innovations, partnerships, and advocacy efforts to reduce the use of animal testing.
- View the full release here: https://www.businesswire.com/news/home/20240416134140/en/
Understanding that stakeholders across drug development must collaborate to pursue these advances, AMAP is comprised of Charles River experts in animal welfare, science, technology, operations, and advocacy. - AMAP focus is on three key pillars:
Products & Services: Charles River is committed to innovating and expanding its portfolio to include more animal alternatives.